Does RAVULIZUMAB-CWVZ Cause Muscular weakness? 422 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 422 reports of Muscular weakness have been filed in association with RAVULIZUMAB-CWVZ. This represents 4.1% of all adverse event reports for RAVULIZUMAB-CWVZ.
422
Reports of Muscular weakness with RAVULIZUMAB-CWVZ
4.1%
of all RAVULIZUMAB-CWVZ reports
2
Deaths
38
Hospitalizations
How Dangerous Is Muscular weakness From RAVULIZUMAB-CWVZ?
Of the 422 reports, 2 (0.5%) resulted in death, 38 (9.0%) required hospitalization.
Is Muscular weakness Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for RAVULIZUMAB-CWVZ. However, 422 reports have been filed with the FAERS database.
What Other Side Effects Does RAVULIZUMAB-CWVZ Cause?
Fatigue (1,472)
Asthenia (727)
Headache (639)
Drug ineffective (570)
Off label use (451)
Dyspnoea (414)
Malaise (353)
Haemoglobin decreased (346)
Myasthenia gravis (338)
Back pain (326)
What Other Drugs Cause Muscular weakness?
ADALIMUMAB (3,605)
METHOTREXATE (2,813)
RITUXIMAB (2,621)
ATORVASTATIN (2,494)
PREDNISONE (2,236)
ETANERCEPT (2,207)
DALFAMPRIDINE (1,916)
TOCILIZUMAB (1,790)
FINGOLIMOD (1,769)
SECUKINUMAB (1,747)
Which RAVULIZUMAB-CWVZ Alternatives Have Lower Muscular weakness Risk?
RAVULIZUMAB-CWVZ vs REBAMIPIDE
RAVULIZUMAB-CWVZ vs REBETOL
RAVULIZUMAB-CWVZ vs REBIF
RAVULIZUMAB-CWVZ vs REBOXETINE
RAVULIZUMAB-CWVZ vs RECLAST